SS Innovations International Inc. (NASDAQ: SSII) Positioned as 'One to Watch' with Innovative Surgical Robotics Platform

SS Innovations International Inc. (NASDAQ: SSII) is emerging as a notable player in the surgical robotics space, driven by its differentiated SSi Mantra system. The company, headquartered in India and expanding globally, is focused on democratizing access to advanced surgical robotic technologies. Since commencing commercial operations in late 2022, SS Innovations has demonstrated robust sales growth, expanding margins, and an increasing mix of recurring revenue.

The SSi Mantra system is clinically validated and offers unique attributes such as cost advantages, capabilities in cardiac and pediatric surgery, ease of use and training, and pioneering telesurgery features. These differentiators have contributed to its early commercial success, positioning the company to address a large and growing addressable market with favorable industry tailwinds.

Dr. Sudhir Srivastava, an acclaimed robotic cardiac surgeon and the company's founder, Chairman and CEO, leads a team of visionary engineers. The SSi Mantra's broad-based surgical robotic applications, modularity, and user friendliness have been key to its adoption. The company's stronghold in India provides a solid foundation, with global expansion underway, including potential catalysts in the US and EU markets.

SS Innovations boasts world-class research and development and manufacturing facilities to support its growth trajectory. The company's aligned and accomplished management team and Board of Directors are focused on executing its strategic vision. For more details on the latest news and updates, visit the company's newsroom at https://ibn.fm/SSII.

InvestorWire, a specialized communications platform, provides advanced wire-grade press release syndication for private and public companies. It is part of the Dynamic Brand Portfolio @IBN, offering access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN, and tailored corporate communications solutions. For more information, visit https://www.InvestorWire.com.

The company's growth is supported by favorable industry tailwinds, including the increasing adoption of robotic-assisted surgery. SS Innovations' focus on cost efficiency and training makes its technology accessible to a broader range of healthcare providers, potentially transforming surgical care in emerging markets and beyond. As the company continues to expand its global footprint, its innovative platform and strategic positioning make it a compelling entity to watch in the surgical robotics sector.